Exponent Inc EXPO
We take great care to ensure that the data presented and summarized in this overview for EXPONENT INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding EXPO
View all-
Black Rock Inc. New York, NY5.99MShares$419 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.25MShares$367 Million0.01% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA4.49MShares$314 Million0.8% of portfolio
-
Conestoga Capital Advisors, LLC2.36MShares$165 Million2.64% of portfolio
-
Geneva Capital Management LLC1.86MShares$130 Million2.24% of portfolio
-
State Street Corp Boston, MA1.86MShares$130 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.59MShares$111 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY1.56MShares$109 Million0.08% of portfolio
-
Morgan Stanley New York, NY1.11MShares$77.9 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX896KShares$62.7 Million0.01% of portfolio
Latest Institutional Activity in EXPO
Top Purchases
Top Sells
About EXPO
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.
Insider Transactions at EXPO
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2025
|
Catherine Corrigan President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,872
+7.88%
|
$196,800
$25.41 P/Share
|
|
Dec 15
2025
|
Catherine Corrigan President & CEO |
SELL
Open market or private sale
|
Direct |
3,225
-3.69%
|
$225,750
$70.74 P/Share
|
|
Dec 15
2025
|
Catherine Corrigan President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,225
+3.56%
|
$80,625
$25.41 P/Share
|
|
Nov 17
2025
|
Catherine Corrigan President & CEO |
SELL
Open market or private sale
|
Direct |
4,900
-2.84%
|
$343,000
$70.47 P/Share
|
|
Nov 17
2025
|
Catherine Corrigan President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,605
+3.14%
|
$151,335
$27.23 P/Share
|
|
Oct 15
2025
|
Catherine Corrigan President & CEO |
SELL
Open market or private sale
|
Direct |
4,930
-2.88%
|
$325,380
$66.81 P/Share
|
|
Oct 15
2025
|
Catherine Corrigan President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,606
+3.17%
|
$151,362
$27.23 P/Share
|
|
Sep 15
2025
|
Catherine Corrigan President & CEO |
SELL
Open market or private sale
|
Direct |
4,905
-2.87%
|
$338,445
$69.97 P/Share
|
|
Sep 15
2025
|
Catherine Corrigan President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,606
+3.18%
|
$151,362
$27.23 P/Share
|
|
Aug 14
2025
|
Catherine Corrigan President & CEO |
SELL
Open market or private sale
|
Direct |
4,896
-2.9%
|
$347,616
$71.15 P/Share
|
|
Aug 14
2025
|
Catherine Corrigan President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,606
+3.22%
|
$151,362
$27.23 P/Share
|
|
Aug 12
2025
|
Joseph Sala Group Vice President |
SELL
Open market or private sale
|
Direct |
1,595
-100.0%
|
$111,650
$70.64 P/Share
|
|
Jun 04
2025
|
Carol Lindstrom Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,525
+17.09%
|
-
|
|
Jun 04
2025
|
Debra Zumwalt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,525
+4.87%
|
-
|
|
Jun 04
2025
|
Paul R Johnston Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,525
+2.44%
|
-
|
|
Jun 04
2025
|
George H. Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,525
+14.88%
|
-
|
|
Jun 04
2025
|
Karen A Richardson Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,525
+4.52%
|
-
|
|
May 27
2025
|
Joseph Rakow Group Vice President |
SELL
Open market or private sale
|
Direct |
1,573
-100.0%
|
$121,121
$77.72 P/Share
|
|
May 23
2025
|
John Pye Group Vice President |
SELL
Open market or private sale
|
Direct |
2,000
-3.23%
|
$152,000
$76.32 P/Share
|
|
May 20
2025
|
Bradley A James Group Vice President |
SELL
Open market or private sale
|
Direct |
2,694
-100.0%
|
$212,826
$79.52 P/Share
|
Last 12 Months Summary
| Exercise of conversion of derivative security | 77.9K shares |
|---|
| Payment of exercise price or tax liability | 12.7K shares |
|---|---|
| Open market or private sale | 32.5K shares |